Clinical Trial Update: At-Home Subcutaneous Immunoglobulin Replacement Therapy Using Alexa Skill

View source ↗

Summary

A Takeda-sponsored clinical trial evaluating at-home subcutaneous immunoglobulin replacement therapy delivered via an Alexa Skill has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immunodeficiency Disease

Drugs mentioned

• Subcutaneous immunoglobulin (SCIG) replacement therapy (immunoglobulin G)

Snippet

Sponsor: Takeda | Conditions: Primary Immunodeficiency Diseases (PID) | Status: COMPLETED